ABVC BioPharma, Inc. (ABVC) Return on equity 2020–2025
ABVC BioPharma, Inc. (ABVC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-71.2%FY2025 · since FY2020: -308.1% → -71.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -71.2% | +328.7 pp |
| FY2024 | -399.9% | +101.3 pp |
| FY2023 | -501.1% | +28.9 pp |
| FY2022 | -530.0% | -384.8 pp |
| FY2021 | -145.2% | +162.9 pp |
| FY2020 | -308.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice